Next steps in understanding the obesity paradox in cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 26, Issue 1, 2017, Pages 12-

  Caan, Bette J ^a   Kroenke, Candyce H ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY COMPOSITION; BODY MASS; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL OUTCOME; DISEASE ASSOCIATION; HUMAN; MALIGNANT NEOPLASM; NOTE; OBESITY; PRIORITY JOURNAL; WEIGHT GAIN; NEOPLASM; PROGNOSIS; RISK FACTOR;

BODY MASS INDEX; HUMANS; NEOPLASMS; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 85009062595     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-16-0764     Document Type: Note

References (6)

1. Cespedes Feliciano EM, Kroenke CH, Bradshaw PT, Chen WY, Prado CM, Weltzien EK, et al. Post-diagnosis weight change and survival following a diagnosis of early stage breast cancer. Cancer Epidemiol Biomarkers Prev 2017;26:44-50.
2. Meyerhardt JA, Kroenke CH, Prado CM, Kwan ML, Castillo A, Weltzien E, et al. Association of weight change after colorectal cancer diagnosis and outcomes in the Kaiser Permanente Northern California population. Cancer Epidemiol Biomarkers Prev 2017;26: 30-7.
3. Greenlee H, Unger JM, LeBlanc M, Ramsey S, Hershman DL. Association between body mass index (BMI) and cancer survival in a pooled analysis of 22 clinical trials. Cancer Epidemiol Biomarkers Prev 2017; 26:21-9.
4. Mayeda ER, Glymour MM. The obesity paradox in survival after cancer diagnosis: Tools for evaluation of potential bias. Cancer Epidemiol Biomarkers Prev 2017;26:17-20.
5. Shachar SS, Williams GR. The obesity paradox in cancer-moving beyond BMI. Cancer Epidemiol Biomarkers Prev 2017;26:13-16.
6. Kinsey CM, San Jose ER, Van der Velden J, Cole BF, Christiani DC, Washko GR. Lower pectoralis muscle area is associated with a worse overall survival in non-small cell lung cancer. Cancer Epidemiol Biomarkers Prev 2017; 26:38-43.